ÂÜÀòÂÒÂ×

Nima Alidoust is a biotechnology entrepreneur and executive with extensive experience in the fields of drug discovery and computational technology. Currently serving as CEO and Co-Founder of Vevo Therapeutics, Nima leads the development of innovative drug discovery platforms utilizing in vivo data generation and advanced AI methodologies. Previously, as Founding CEO of Good Chemistry Company, Nima spearheaded efforts in AI-driven chemical simulations, resulting in a $75M acquisition. Nima's background includes a role as Vice President of Product and Strategy at Rigetti Computing, contributing to the development of quantum computing applications, and as a Senior Associate at McKinsey & Company, providing strategic insights to clients in advanced industries. Educational achievements include a Ph.D. in Computational and Quantum Chemistry from Princeton University and a B.A. in Physics and Classics from Middlebury College.